Sources | Names Used |
---|---|
CTRPv2 | selumetinib:BRD-A02303741 (4:1 mol/mol) |
PharmacoGx | selumetinib:BRD-A02303741 (4:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | RBMS3 | CTRPv2 | pan-cancer | AAC | -0.17 | 5e-05 |
mRNA | WDHD1 | CTRPv2 | pan-cancer | AAC | -0.14 | 5e-05 |
mRNA | KIF5C | CTRPv2 | pan-cancer | AAC | -0.16 | 5e-05 |
mRNA | RP11-101E3.5 | CTRPv2 | pan-cancer | AAC | -0.14 | 5e-05 |
mRNA | MT-CO1 | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-05 |
mRNA | PAPOLG | CTRPv2 | pan-cancer | AAC | -0.15 | 5e-05 |
mRNA | KRT20 | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-05 |
mRNA | TFDP2 | CTRPv2 | pan-cancer | AAC | -0.15 | 5e-05 |
mRNA | RILP | CTRPv2 | pan-cancer | AAC | 0.14 | 5e-05 |
mRNA | RP11-15H20.8 | CTRPv2 | pan-cancer | AAC | -0.15 | 5e-05 |